Literature DB >> 21042752

Tamoxifen-induced apoptosis of rat C6 glioma cells via PI3K/Akt, JNK and ERK activation.

Ying Feng1, Jintao Huang, Ying Ding, Fukang Xie, Xiaoyan Shen.   

Abstract

To elucidate the mechanism of TAM treatment on gliomas, we hypothesised that PI3K/Akt and MAPK signaling pathway may play important roles on TAM-induced apoptosis in C6 glioma cells. Our results demonstrated that TAM induced apoptosis of C6 glioma cells in a dose-dependent manner. The activation of AKT significantly decreased in a time-dependent manner in response to TAM treatment, JNK was transiently activated, and subsequently decreased activation and kept stable level, whereas ERK evidenced sustained activations in response to the drug treatment. The inhibition of PI3K/Akt and JNK both accelerated and enhanced TAM-induced apoptosis and ERK inhibition apparently exerted negative effect on apoptosis. We also observed that PI3K/Akt had intimate association with JNK and ERK activation in TAM-induced apoptosis. These findings may provide strategies for the molecularly targeted therapy in malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042752     DOI: 10.3892/or_00001018

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Optimized mixture of As, Cd and Pb induce mitochondria-mediated apoptosis in C6-glioma via astroglial activation, inflammation and P38-MAPK.

Authors:  Weiming He; Yingfu Li; Jingyan Tian; Ning Jiang; Bo Du; Yuping Peng
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Tamoxifen induces apoptosis of mouse microglia cell line BV-2 cells via both mitochondrial and death receptor pathways.

Authors:  Zhengwei Li; Jincao Chen; Ting Lei; Huaqiu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

3.  CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.

Authors:  Paul L Prather; FeAna FrancisDevaraj; Centdrika R Dates; Aleksandra K Greer; Stacie M Bratton; Benjamin M Ford; Lirit N Franks; Anna Radominska-Pandya
Journal:  Biochem Biophys Res Commun       Date:  2013-10-19       Impact factor: 3.575

Review 4.  Tamoxifen non-estrogen receptor mediated molecular targets.

Authors:  Tatiana Bogush; Evgeny Dudko; Elena Bogush; Boris Polotsky; Sergei Tjulandin; Mikhail Davydov
Journal:  Oncol Rev       Date:  2012-10-04

5.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

6.  CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.

Authors:  Zhai Yang; Qing Xie; Cheng-Liang Hu; Qiong Jiang; Hui-Fan Shen; Melitta Schachner; Wei-Jiang Zhao
Journal:  Front Mol Neurosci       Date:  2017-10-17       Impact factor: 5.639

Review 7.  Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders.

Authors:  Mohammad M Khan
Journal:  Int J Endocrinol       Date:  2018-10-08       Impact factor: 3.257

8.  Tamoxifen Exerts Anticancer Effects on Pituitary Adenoma Progression via Inducing Cell Apoptosis and Inhibiting Cell Migration.

Authors:  Tingting Lv; Zirui Zhang; Haoying Yu; Shuyue Ren; Jingrong Wang; Shang Li; Lan Sun
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

9.  Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.

Authors:  Naoshad Mohammad; Parmanand Malvi; Avtar Singh Meena; Shivendra Vikram Singh; Balkrishna Chaube; Garikapati Vannuruswamy; Mahesh J Kulkarni; Manoj Kumar Bhat
Journal:  Mol Cancer       Date:  2014-09-01       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.